PortalPublikationenDevelopment and Validation of the Patient Benefit Index for ...

Development and Validation of the Patient Benefit Index for the Dermatocosmetic Treatment of Aged Skin

Standard

Development and Validation of the Patient Benefit Index for the Dermatocosmetic Treatment of Aged Skin. / Lohrberg, David; Blaak, Jürgen; Liebsch, Juliane; Staib, Peter; Wohlfart, Rainer; Lüttje, Dieter; Schürer, Nanna Y; Augustin, Matthias; Blome, Christine.

in: ARCH DERMATOL RES, Jahrgang 308, Nr. 5, 07.2016, S. 319-324.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Lohrberg, D, Blaak, J, Liebsch, J, Staib, P, Wohlfart, R, Lüttje, D, Schürer, NY, Augustin, M & Blome, C 2016, 'Development and Validation of the Patient Benefit Index for the Dermatocosmetic Treatment of Aged Skin', ARCH DERMATOL RES, Jg. 308, Nr. 5, S. 319-324. https://doi.org/10.1007/s00403-016-1648-5

APA

Lohrberg, D., Blaak, J., Liebsch, J., Staib, P., Wohlfart, R., Lüttje, D., Schürer, N. Y., Augustin, M., & Blome, C. (2016). Development and Validation of the Patient Benefit Index for the Dermatocosmetic Treatment of Aged Skin. ARCH DERMATOL RES, 308(5), 319-324. https://doi.org/10.1007/s00403-016-1648-5

Vancouver

Lohrberg D, Blaak J, Liebsch J, Staib P, Wohlfart R, Lüttje D et al. Development and Validation of the Patient Benefit Index for the Dermatocosmetic Treatment of Aged Skin. ARCH DERMATOL RES. 2016 Jul;308(5):319-324. https://doi.org/10.1007/s00403-016-1648-5

Bibtex

@article{32443365678244a08030609c42fb7b92,
title = "Development and Validation of the Patient Benefit Index for the Dermatocosmetic Treatment of Aged Skin",
abstract = "This study aimed to develop and validate an instrument for the assessment of patient-relevant benefit in dermatocosmetic treatment, i.e., skin care, of aged skin. Based on an open item collection with 33 elderly persons, items on patient-relevant treatment goals were collected. An expert panel selected 20 items to be most relevant and feasible for the questionnaire named Patient Benefit Index for Aged Skin (PBI-AS). The instrument, which assesses goal importance and achievement, was tested in a cognitive debriefing and validated in a longitudinal study (n = 80) along with the Dry Skin Area and Severity Index (DASI) and the Dermatology Quality of Life Index (DLQI) as convergent validation criteria. The cognitive debriefing showed the good practicability and feasibility of the instrument. Significant correlation with change in DASI (r = -0.527; p < 0.001) supports convergent validity of the PBI-AS. By contrast, correlation with DLQI was poor, indicating the different constructs. The PBI-AS is a valid and feasible tool for the patient-centered assessment of dermatocosmetic treatment benefit in aged skin.",
keywords = "Journal Article",
author = "David Lohrberg and J{\"u}rgen Blaak and Juliane Liebsch and Peter Staib and Rainer Wohlfart and Dieter L{\"u}ttje and Sch{\"u}rer, {Nanna Y} and Matthias Augustin and Christine Blome",
year = "2016",
month = jul,
doi = "10.1007/s00403-016-1648-5",
language = "English",
volume = "308",
pages = "319--324",
journal = "ARCH DERMATOL RES",
issn = "0340-3696",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - Development and Validation of the Patient Benefit Index for the Dermatocosmetic Treatment of Aged Skin

AU - Lohrberg, David

AU - Blaak, Jürgen

AU - Liebsch, Juliane

AU - Staib, Peter

AU - Wohlfart, Rainer

AU - Lüttje, Dieter

AU - Schürer, Nanna Y

AU - Augustin, Matthias

AU - Blome, Christine

PY - 2016/7

Y1 - 2016/7

N2 - This study aimed to develop and validate an instrument for the assessment of patient-relevant benefit in dermatocosmetic treatment, i.e., skin care, of aged skin. Based on an open item collection with 33 elderly persons, items on patient-relevant treatment goals were collected. An expert panel selected 20 items to be most relevant and feasible for the questionnaire named Patient Benefit Index for Aged Skin (PBI-AS). The instrument, which assesses goal importance and achievement, was tested in a cognitive debriefing and validated in a longitudinal study (n = 80) along with the Dry Skin Area and Severity Index (DASI) and the Dermatology Quality of Life Index (DLQI) as convergent validation criteria. The cognitive debriefing showed the good practicability and feasibility of the instrument. Significant correlation with change in DASI (r = -0.527; p < 0.001) supports convergent validity of the PBI-AS. By contrast, correlation with DLQI was poor, indicating the different constructs. The PBI-AS is a valid and feasible tool for the patient-centered assessment of dermatocosmetic treatment benefit in aged skin.

AB - This study aimed to develop and validate an instrument for the assessment of patient-relevant benefit in dermatocosmetic treatment, i.e., skin care, of aged skin. Based on an open item collection with 33 elderly persons, items on patient-relevant treatment goals were collected. An expert panel selected 20 items to be most relevant and feasible for the questionnaire named Patient Benefit Index for Aged Skin (PBI-AS). The instrument, which assesses goal importance and achievement, was tested in a cognitive debriefing and validated in a longitudinal study (n = 80) along with the Dry Skin Area and Severity Index (DASI) and the Dermatology Quality of Life Index (DLQI) as convergent validation criteria. The cognitive debriefing showed the good practicability and feasibility of the instrument. Significant correlation with change in DASI (r = -0.527; p < 0.001) supports convergent validity of the PBI-AS. By contrast, correlation with DLQI was poor, indicating the different constructs. The PBI-AS is a valid and feasible tool for the patient-centered assessment of dermatocosmetic treatment benefit in aged skin.

KW - Journal Article

U2 - 10.1007/s00403-016-1648-5

DO - 10.1007/s00403-016-1648-5

M3 - SCORING: Journal article

C2 - 27117448

VL - 308

SP - 319

EP - 324

JO - ARCH DERMATOL RES

JF - ARCH DERMATOL RES

SN - 0340-3696

IS - 5

ER -